Terminated OBSERVATIONAL NCT05998785

Embody Insertional Achilles Tendinopathy (IAT)

A Multi-Center, Prospective Case Series Evaluating Insertional Achilles Tendinopathy Repair Augmented with TAPESTRY® Biointegrative Implant

Sponsor: Embody Inc.

Conditions Insertional Achilles Tendinopathy

Interventions TAPESTRY Biointegrative Implant

Updated 5 times since 2023 Last updated: Dec 17, 2024 Started: Aug 2, 2022 Primary completion: Aug 1, 2024 Completion: Aug 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Administrative issues with IRB, none of which impacted the health/safety/welfare of the subjects, has resulted in enrollment suspension and subsequent study termination.

This observational or N/A phase trial investigates Insertional Achilles Tendinopathy and is currently terminated or withdrawn. Embody Inc. leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Terminated

Status: Suspended → Terminated
Sep 2024 — Jan 2025 [monthly]

Suspended
Jul 2024 — Sep 2024 [monthly]

Suspended
Jan 2024 — Jul 2024 [monthly]

Suspended

Status: Enrolling By Invitation → Suspended
Sep 2023 — Jan 2024 [monthly]

Enrolling By Invitation

First recorded

Aug 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Embody Inc.
Zimmer Biomet

Data source: Zimmer Biomet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Libertyville, United States
• Tulsa, United States